GE patient monitor app receives FDA clearance

Jeff Byers | November 03, 2010 | Health Exec | Precision Medicine

The FDA has cleared GE Healthcare's patient monitoring application Carescape Monitor B650.

The Carescape Monitor B650 assists data integration and connectivity by linking to the GE Carescape portfolio of monitoring products--including bedside, central station and transport monitors--as well as existing GE monitors and peripheral third-party devices.

According to GE, the enterprise-wide patient monitoring platform assists clinical decision-making via:

Customized patient profiles within the monitor or plug in a new clinical measurement module;

A touch screen interface and a barcode reader. From the system, caregivers can view data and alarms from remote monitors at bedside; and

The monitor can run via a wireless local area network, can be battery operated and transmits data to the central station.

Jeff Byers

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

GE patient monitor app receives FDA clearance

Related Content

Around the web